|
PPIB expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | <1E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.11022302462516E-16 |
| Normal-vs-Stage2 |
6.7666999781224E-09 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
1.62547753035369E-12 |
| Stage1-vs-Stage2 |
3.046200E-01 |
| Stage1-vs-Stage3 |
1.612830E-04 |
| Stage1-vs-Stage4 |
1.61243999999838E-05 |
| Stage2-vs-Stage3 |
1.404960E-01 |
| Stage2-vs-Stage4 |
4.522600E-03 |
| Stage3-vs-Stage4 |
4.665700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62447832963153E-12 |
| Normal-vs-AfricanAmerican |
1.36569999753533E-09 |
| Normal-vs-Asian |
6.480000E-02 |
| Caucasian-vs-AfricanAmerican |
8.519800E-01 |
| Caucasian-vs-Asian |
8.447200E-01 |
| AfricanAmerican-vs-Asian |
8.130800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62447832963153E-12 |
| Normal-vs-Female |
<1E-12 |
| Male-vs-Female |
3.830800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.79818999999082E-05 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
<1E-12 |
| Normal-vs-Age(81-100Yrs) |
3.629100E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.676840E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.874600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.207400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.951000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.938400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.208400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.5964000000055E-05 |
| Normal-vs-Grade 2 |
1.62447832963153E-12 |
| Normal-vs-Grade 3 |
<1E-12 |
| Normal-vs-Grade 4 |
1.62503344114384E-12 |
| Grade 1-vs-Grade 2 |
3.179200E-01 |
| Grade 1-vs-Grade 3 |
1.205660E-02 |
| Grade 1-vs-Grade 4 |
1.14699999997914E-06 |
| Grade 2-vs-Grade 3 |
6.976000E-04 |
| Grade 2-vs-Grade 4 |
1.01679999975346E-07 |
| Grade 3-vs-Grade 4 |
1.020070E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
<1E-12 |
| Normal-vs-ccB subtype |
<1E-12 |
| ccA subtype-vs-ccB subtype |
5.17659999976772E-07 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
1.50870000004133E-06 |
| N0-vs-N1 |
5.833600E-02 |
|
|
